Oncology

The CGTLive™ Oncology specialty topic page highlights the latest clinical care news related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for various cancers. It also houses video interviews with key opinion leaders in the field of oncology speaking to the related FDA actions, clinical guideline updates, and clinical trial findings in the field of gene and cell therapy for oncologic diseases.

Latest News

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – June 13, 2025

June 13th 2025

Review top news and interview highlights from the week ending June 13, 2025.

Dual-Target CD19/CD20 CAR T-Cell Therapy Achieves 63.6% Complete Remission Rate in R/R B-NHL
Dual-Target CD19/CD20 CAR T-Cell Therapy Achieves 63.6% Complete Remission Rate in R/R B-NHL

June 13th 2025

Academic CD19-Directed CAR-T Therapy Shows 86.7% ORR in Follicular Lymphoma
Academic CD19-Directed CAR-T Therapy Shows 86.7% ORR in Follicular Lymphoma

June 12th 2025

Deevyashali Parekh, MBBS, an internal medicine resident at SUNY Upstate Medical University Hospital
Deevyashali Parekh, MBBS, on Evaluating the Prevalence of Second Primary Malignancies After CAR T-Cell Therapy

June 12th 2025

Around the Helix: Cell and Gene Therapy Company Updates – June 11, 2025
Around the Helix: Cell and Gene Therapy Company Updates – June 11, 2025

June 11th 2025

Video Interviews
Podcasts
ImmunoLogic Episode 4
ImmunoLogic
ImmunoLogic
ImmunoLogic
ImmunoLogic

More News

© 2025 MJH Life Sciences

All rights reserved.